Cabinet endorses NSC stance over Trump remarks

Sophia Siddiqui

Islamabad

The federal cabinet in its meeting on Wednesday with Prime Minister Shahid Khaqan Abbasi in the chair unanimously endorsed the stance of National Security Committee of the cabinet, which had expressed deep disappointment over recent statements of the American leadership.
The cabinet viewed that the American statements were detrimental to the bilateral relationship between Pakistan and the United States, a relationship that had been developed over generations, PM Office media wing said in a press release.
“Pakistan has rendered huge sacrifices, both in terms of loss of precious human lives and substantial damage to the economy. Achievements made by Pakistan in curbing the menace of terrorism have been acknowledged throughout the world,” it added. At the outset of the meeting, Foreign Minister Khawaja Muhammad Asif briefed the cabinet about the background of the recent statements by the American leadership and the discussion held during a meeting of the National Security Committee of the cabinet yesterday.
The cabinet also considered other agenda items as well. It considered a proposal for granting extension in the Proof of Registration Cards and Tripartite Agreement (Pakistan-Afghanistan-UNHCR) for Afghan Refugees beyond 31st December, 2017. After detailed discussion, the cabinet agreed to grant only 30 days extension for POR and also decided that the issue of early repatriation of Afghan refugees should be raised with the UNHCR and with the international community.
Pakistan’s economy had carried the burden of hosting Afghan refugees since long and in the present circumstances could not sustain it further, the cabinet emphasized.
The federal cabinet accorded approval for publication of block level provisional results of Census 2017. The agenda item of approval of maximum retail prices (MRPs) of additional pack sizes of already registered drugs, approval of increase in maximum retail prices of drugs under para 8 of the Drug Pricing Policy-2015 and Threshold Limits of Lower Priced Drugs under para 11 of the Drug Pricing Policy-2015 were discussed at length and the cabinet accorded approval as per Drug Pricing Policy 2015.—APP

Share this post

PinIt
    scroll to top